Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca in Parkinson’s race
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca [...]
GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuro
GlaxoSmithKline, University of Oxford join forces in $40M digital deep [...]
Tune Therapeutics’ epigenetic platform resonates with investors as it snags $40M in financing
Tune Therapeutics’ epigenetic platform resonates with investors as it snags [...]
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer models
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer [...]
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks [...]
Vertex once again talks up a tiny trial with positive read-throughs, this time for a genetically driven approach to kidney disease
Vertex once again talks up a tiny trial with positive [...]
Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy
Sanofi snaps up Origimm for early-phase acne vaccine, opening new [...]
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Mei, with Bayer and Gilead in its sights, posts pivotal [...]
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D [...]
RAGE against diabetes complications: Novel drug tamps down tissue damage in mice
RAGE against diabetes complications: Novel drug tamps down tissue damage [...]